AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 12, 2024. Key executives, including President and COO Robert A. Michael, CFO Scott T. Reents, CCO Jeffrey R. Stewart, and Chief Medical Officer Dr. Roopal Thakkar, will present at 9:00 a.m. Central time. Investors can access a live audio webcast through AbbVie's Investor Relations website, with an archived version available later in the day.
- None.
- None.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-45th-annual-global-healthcare-conference-302161924.html
SOURCE AbbVie